The clinical and immunological spectrum of American cutaneous leishmaniasisCONVIT, J; ULRICH, M; FERNANDEZ, C. T et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 1993, Vol 87, Num 4, pp 444-448, issn 0035-9203Conference Paper

Demonstration of an indomethacin-sensitive mechanism regulating immune reactivity in American cutaneous leishmaniasis patientsCASTES, M; TRUJILLO, D; SCOTT, D et al.Clinical and experimental immunology (Print). 1987, Vol 69, Num 2, pp 280-290, issn 0009-9104Article

Cell-mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapyCASTES, M; MOROS, Z; MARTINEZ, A et al.Parasite immunology. 1989, Vol 11, Num 3, pp 211-222, issn 0141-9838Article

In situ characterization of the cellular immune response in American cutaneous leishmaniasisMODLIN, R. L; TAPIA, F. J; BLOOM, B. R et al.Clinical and experimental immunology (Print). 1985, Vol 60, Num 2, pp 241-248, issn 0009-9104Article

Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesionDIAZ, N. L; ZERPA, O; PONCE, L. V et al.Experimental dermatology. 2002, Vol 11, Num 1, pp 34-41, issn 0906-6705Article

Mechanisms associated with immunoregulation in human American cutaneous leishmaniasisCASTES, M; AGNELLI, A; RONDON, A. J et al.Clinical and experimental immunology (Print). 1984, Vol 57, Num 2, pp 279-286, issn 0009-9104Article